Health Care & Life Sciences » Pharmaceuticals | Neos Therapeutics Inc.

Neos Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
90,763.00
39,782.00
50,417.00
46,478
Total Accounts Receivable
3,903.00
6,135.00
13,671.00
27,801
Inventories
2,520.00
5,767.00
13,459.00
10,367
Other Current Assets
1,058.00
2,865.00
5,093.00
4,032
Total Current Assets
98,244.00
54,549.00
82,640.00
88,678
Net Property, Plant & Equipment
5,124.00
7,076.00
8,203.00
7,914
Intangible Assets
18,945.00
17,647.00
16,348.00
14,616
Other Assets
197.00
870.00
162.00
149
Total Assets
122,510.00
80,142.00
107,353.00
111,357
ST Debt & Current Portion LT Debt
7,973.00
4,921.00
896.00
Accounts Payable
4,824.00
7,798.00
11,460.00
Other Current Liabilities
3,141.00
8,926.00
25,246.00
Total Current Liabilities
15,938.00
21,645.00
37,602.00
Long-Term Debt
26,271.00
58,599.00
58,938.00
Provision for Risks & Charges
214.00
232.00
-
Other Liabilities
1,713.00
1,214.00
2,923.00
Total Liabilities
44,136.00
81,690.00
99,463.00
Common Equity (Total)
78,374.00
1,548.00
7,890.00
Total Shareholders' Equity
78,374.00
1,548.00
7,890.00
Total Equity
78,374.00
1,548.00
7,890.00
Liabilities & Shareholders' Equity
122,510.00
80,142.00
107,353.00

About Neos Therapeutics

View Profile
Address
2940 North Highway 360
Grand Prairie Texas 75050
United States
Employees -
Website http://www.neostx.com
Updated 07/08/2019
Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. In addition, Neos manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold.